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The mechanism of action for a,b-unsaturated lactones can be explained by their Michael acceptor
properties. They have the potential of being covalently binding inhibitors by accepting nucleophiles from
target proteins. In this work, Michael addition reactions of ethanethiol with 6-bicycloaryl substituted 5,6-
dihydro-2H-pyran-2-ones were studied to explore the existence of such interactions. Three of the
Michael addition products were isolated and tested over PC3 (human prostate cancer) and MCF-7 (human
breast adenocarcinoma) cancer cell lines and no cytotoxicity was observed. It was revealed that biological
activity depends on the existence of a Michael acceptor, but potency probably depends upon the 3D
structure of the substituent on lactone ring. The primary chemical-quantum properties of the lactones
were also calculated using the Spartan’08 computer program.
 2010 Elsevier Inc. All rights reserved.Many biologically active natural compounds possess a,b-unsat-
urated d-lactones in their structures as a unique pharmacore. It is
believed that, because of their ability to behave as a Michael accep-
tor, these unsaturated carbonyls can bind themselves to the nucle-
ophilic part of a target enzyme [1]. It is very difficult to explain why
this class of molecules directly reacts with a specific target while
there are potentially many other target nucleophiles within the
same cell. Goniothalamin (from Cryptocarya caloneura) [2], cytosta-
tin (from Streptomyces sp. MJ654-NF4) [3], and fostriecin (from
Streptomyces pulveraceus) [4] are examples showing cytotoxicity
against human cancer cell lines at submicromolar concentrations.
Recently in our laboratory, goniothalamin (1) has been shown
as a potential lead molecule for the synthesis of eight new bicyclo-
aryl substituted a,b-unsaturated-d-lactones and their cytotoxic
properties against PC3 and MCF-7 tumor cell lines have been eval-
uated [5]. Six of the most cytotoxic of these are represented in
Fig. 1. Interestingly, compounds 1–5were cytotoxic at submicrom-
olar concentrations while compound 7 showed cytotoxicity at the
nanomolar range whereas compound 6 was the most cytotoxic
having an IC50 of 50 nM for PC3 cell lines [5].
Here, computer modeling software was used to help understand
why, out of compounds 1–7, compounds 6 and 7 showed enhanced
cytotoxicity. Michael addition reactions of ethanethiol to com-ll rights reserved.
hnology, Faculty of Science,
Fax: +90 232 7507509.pounds 1–7 were studied to explore their relative reactivities with
sulfhydryl based nucleophiles in biological systems.
Energy minimization of compounds 1–7 has been calculated
using the Spartan’08 [6] software via the semi-empirical AM1
method. The primary chemical-quantum properties of lactones
were also calculated by the same method. Results of the calcula-
tions are summarized in Table 1.
Compounds 1–7 were prepared as previously reported litera-
ture [5]. To carry out Michael addition reactions simply, 5–10 mg
of compounds (1–7) was dissolved in DMSO-d6 and then a blank
1H NMR was acquired. Then one equivalent of ethanethiol was
added with a syringe and mixed well. Ten minutes after the addi-
tion of ethanethiol, a subsequent 1H NMR spectrum was taken. If
the reactions were not complete within 10 min, then reactions
were monitored by taking an 1H NMR spectrum taken at continued
appropriate intervals. The rate of the reactions were evaluated by
the disappearance of signals belonging to protons attached to the
a,b-unsaturated carbons as well as the signals from the appearance
of new diastereomeric saturated protons.
To determine the cytotoxicity of the compounds, MTT assay
were performed under the same condition reported in literature
at 0.1, 0.5, 1, 10, and 50 lM concentrations [5].
The Corey–Pauling–Koltun (CPK) space-filling model volume
and area for compounds 6 and 7 were approximately 20 units
(Å3 and Å2) higher than for compounds 1–5. Log P values (measure-
ment of permeability of the cell membrane) for compounds 6 and 7
were the same (3.87), but higher than the Log P values for com-
pounds 2 and 4 (3.38). Log P values for the quinoline derivatives
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Fig. 1. Structure of goniothalamin (1) and 6-bicycloaryl substituted (R)-5,6-dihydro-2H-pyran-2-ones (2–7).
Table 1
Calculated main chemical-quantum properties of compounds 1–7.
Comp. CPK area (Å2) CPK volume (Å3) PSA (Å2) Log P (Crippen
model)
1 236.06 218.33 21.82 2.90
2 245.15 236.70 21.32 3.38
3 240.62 230.47 28.56 2.47
4 241.96 236.11 20.68 3.38
5 237.42 229.96 27.82 2.47
6 262.23 254.40 19.65 3.87
7 259.85 253.97 20.87 3.87
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Plotting the known IC50 values for the compounds [5] as a function-5
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Fig. 2. Relationship between Log P (Crippen model) and IC50 values for the cof lipophilicity, it is seen that in general, as lipophilicity increases,
cytotoxicity increases for compounds 1–7 (Fig. 2). It seems plausi-
ble that 6-bicycloaryl substituted 5,6-dihydro-2H-pyran-2-ones,
having higher CPK volumes, areas, and lipophilicities, demonstrate
higher cytotoxicity.
There is not any other similar biologically active molecule,
which can be pooled in this QSAR study or can be discussed. Only
goniothalamin derivatives can be considered as structurally rele-
vant molecules. Interestingly, Zhou and his coworkers had synthe-
sized 14 goniothalamin derivatives and evaluated their
cytotoxicities [7]. In the same work the authors reported that
derivatives of goniothalamin, having Log P values between +4.4
and +4.7, possessed good activities (IC50 was 0.18–0.68 lg/mL).
Their result is completely parallel to our findings.3 3.5 4
rippen model)
Linear (MCF-7) Linear (PC-3)
ytotoxicity of compounds 1–7 against MCF-7 and PC3 cancer cell lines.
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Fig. 3. Michael addition reactions of ethanethiol with goniothalamin (1) and 6-
bicycloaryl substituted (R)-5,6-dihydro-2H-pyran-2-ones (2–7).
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tions of ethanethiol to biologically active a,b-unsaturated carbon-
yls were used to understand the relative reactivity of compounds
with similar thiol-based nucleophiles in biological systems, some-
times also being accepted as the actual source of biological activity
[8–12]. Similarly reactions of ethanethiol with (R)-goniothalamin
(1) and 6-bicycloaryl substituted 5,6-dihydro-2H-pyran-2-ones
(2–7) can be useful to rationalize their relative cytotoxicity and
to find any explanation for the greater cytotoxicity of 1-naphthyl
substituted 5,6-dihydro-2H-pyran-2-ones (Fig. 3).Table 2
1H NMR chemical shift for lactones in compounds 1–7.
Comp. CH CH2
da (ppm) Multiplets (J in Hz) da (ppm) Multiplets (J in Hz)
1 5.15 dt (10.2, 5.0, 5.0) 2.54 m
2 5.71 dd (8.0, 8.0) 2.76 m
3 5.85 dd (9.3, 6.7) 2.87 m
4 6.33 dd (11.4, 4.6) 2.84 m
5 6.43 dd (11.8, 4.2) 2.78, and 2.91 m, and m
6 6.34 dd (13.3, 4.5) 3.07, and 2.66 m, and ddd (19, 8, 1
7 6.29 dd (11.7, 4.3) 2.82 m
Water peak was used as reference at 3.33 ppm.
a NMRs were recorded at 400 MHz using Varian NMR spectrophotometer and process
Fig. 4. Reaction between ethanethiol and (R)-goniothalamin (1) in DMSO-d6. 1H NMR 1
(10 min); 1H NMR 3. (R)-goniothalamin + EtSH in 1:0.75 ratios (20 min); 1H NMR 4. (R)-1H NMR chemical shifts, multiplicities, and coupling constants
of the lactones subunit for compounds 1–7 are listed in Table 2.
For compounds 2–7, signals belonging to protons attached to the
b-carbon shifted downfield to a greater extent than that those
associated with (R)-goniothalamin by 0.1 ppm. It is expected that
b-carbons of lactones 2–7 should be more electron deficient than
the b-carbon of goniothalamin allowing them to react faster.
When (R)-goniothalamin (1) was reacted with 0.75 equivalent
of ethanethiol, the intensity of the signals for the a and b-carbons,
at 6.01 and 7.08 ppm respectively, diminished after 10 min. Addi-
tionally, the peak for the benzylic proton at 5.15 ppm was getting
smaller while two new multiplets appeared at 5.24 and 5.04 ppm,
indicating the formation of two unknown diastereomers in the ra-
tio 1:4. When the amount of ethanethiol was increased to two
equivalents, the peaks for the a and b protons completely disap-
peared. At the same time, formation of two unknown diastereo-
mers was completed at a ratio of 1:5. The reaction between
goniothalamin and excess nucleophile was quite fast, with the en-
tire reaction being completed in less than 10 min (Fig. 4).
Similarly, reactions between ethanethiol and pyranones (2–5
and 6) were completed in less than 10 min. In brief, peaks belong-a CH b CH
da (ppm) Multiplets (J in Hz) da (ppm) Multiplets (J in Hz)
6.01 dd (9.9, 1.2) 7.08 m
6.10 d (9.74) 7.17 m
6.15 dt (9.7, 1.7, 1.7) 7.23 ddd (9,7, 5.6, 3.6)
6.14 ddd (9.7, 2.5, 1.0) 7.21 ddd (9.7, 5.8, 2.6)
6.18 m 7.22 ddd (9.7, 6.0, 2.5)
2.2, 6.8) 6.17 dd (9.9, 1.8) 7.22 ddd (9.8, 6.2, 1.9)
6.13 ddd (9.7, 2.5, 0,8) 7.21 ddd (9.7, 5.9, 2.5)
ed by MestreNOVA in DMSO-d6.
. only (R)-goniothalamin (1); 1H NMR 2. (R)-goniothalamin + EtSH in 1:0.75 ratios
goniothalamin + EtSH in 1:2 ratios (10 min).
Fig. 5. Reaction between ethanethiol and compound 4 in DMSO-d6. 1H NMR (1) only compound 4; 1H NMR (2) compound 4 + EtSH in 1:1.3 ratios (10 min).
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for the benzylic protons shifted downfield (Table 2). Formation of
new doublets of doublets were observed at 5.78 (10.5, and
3.6 Hz); 5.94 (10.8, and 3.7 Hz); 6.42 (10.4, and 3.4 Hz); 6.50 (9.0,
and 4.7 Hz); and 6.39 (10.4, and 3.3 Hz) ppm for the benzylic pro-
tons of products 9–13. The 1H NMR spectrum, showing the reaction
between ethanethiol and compound 4, are given in Fig. 5 as an
example. It seems that there is no difference at all between the
kinetics of Michael addition reactions, so enhanced cytotoxicity
of 1-naphthyl substituted 5,6-dihydro-2H-pyran-2-ones may not
be explained by kinetic issues.
Moreover, ethanethiol addition products for compounds 1, 2,
and 4 were purified on a silica gel column and tested against PC3
and MCF-7 cancer cell lines to evaluate the importance of unsatu-
rated lactones for biological activity. No cytotoxicity was seen
when the MTT assay [5] was applied at 0.1, 0.5, 1, 10, and 50 lM.
Lack of cytotoxicity can be explained either by the steric hindrance
of the ethanethiol component or the lack of a Michael acceptor on
the lactone rings of tested compounds. Hence, these results implies
that higher Log P values and existence of 5,6-dihydro-2H-pyran-2-
one subunit is quite crucial for the biological activity of tested
compounds 1–7.
In literature it is believed that the Michael addition of the nucle-
ophilic site of proteins to the b-carbons of a,b-unsaturated car-
bonyl is responsible element for the biological activity. Although
it is also true for the derivatives reported in here, potencies of
those are not directly related with the kinetics of Michael addition
reaction. We believe that Log P values and three dimensional struc-
tures of the substituents are as much important as Michael accep-
tor properties of compounds 1–7.
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